When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
The FDA approves Novartis' (NYSE:NVS) Mayzent (siponimod) for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome (defined as a first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination in the central nervous system), relapsing remitting disease, and active secondary progressive disease, in adults.
More news on: Novartis AG, Cohen & Steers, Inc., Celgene Corporation, Healthcare stocks news, Stocks on the move,